NCT07305922Recruiting
Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension
Source: ClinicalTrials.gov · Last updated 26 Dec 2025
Brief summary (registry, in English)
An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 7 Dec 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Region Stockholm
- Diseases
- High blood pressure
- NCT number
- NCT07305922
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Dec 2025 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Anticipated survival less than five days, as determined by treating clinician
- Transcranial Doppler signal too weak
- Pregnancy
Who the study is looking for
- Adults 18 years or older
- Critical care after subarachnoid haemorrhage
- Aneurysm secured by surgical clipping or endovascular procedure
- Suspected, emerging or established severe cerebral vasospasm
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.